Literature DB >> 27059856

The epigenetic regulator Smchd1 contains a functional GHKL-type ATPase domain.

Kelan Chen1, Renwick C J Dobson2, Isabelle S Lucet1, Samuel N Young3, F Grant Pearce4, Marnie E Blewitt1, James M Murphy5.   

Abstract

Structural maintenance of chromosomes flexible hinge domain containing 1 (Smchd1) is an epigenetic regulator that plays critical roles in gene regulation during development. Mutations in SMCHD1 were recently implicated in the pathogenesis of facioscapulohumeral muscular dystrophy (FSHD), although the mechanistic basis remains of outstanding interest. We have previously shown that Smchd1 associates with chromatin via its homodimeric C-terminal hinge domain, yet little is known about the function of the putative GHKL (gyrase, Hsp90, histidine kinase, MutL)-type ATPase domain at its N-terminus. To formally assess the structure and function of Smchd1's ATPase domain, we have generated recombinant proteins encompassing the predicted ATPase domain and the adjacent region. Here, we show that the Smchd1 N-terminal region exists as a monomer and adopts a conformation resembling that of monomeric full-length heat shock protein 90 (Hsp90) protein in solution, even though the two proteins share only ∼8% overall sequence identity. Despite being monomeric, the N-terminal region of Smchd1 exhibits ATPase activity, which can be antagonized by the reaction product, ADP, or the Hsp90 inhibitor, radicicol, at a nanomolar concentration. Interestingly, introduction of an analogous mutation to that identified in SMCHD1 of an FSHD patient compromised protein stability, suggesting a possible molecular basis for loss of protein function and pathogenesis. Together, these results reveal important structure-function characteristics of Smchd1 that may underpin its mechanistic action at the chromatin level.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  GHKL-ATPase; Hsp90; Smchd1

Mesh:

Substances:

Year:  2016        PMID: 27059856     DOI: 10.1042/BCJ20160189

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  9 in total

1.  Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans.

Authors:  Chen-Yu Wang; Harrison Brand; Natalie D Shaw; Michael E Talkowski; Jeannie T Lee
Journal:  Genetics       Date:  2019-08-16       Impact factor: 4.562

2.  SMCHD1 Merges Chromosome Compartments and Assists Formation of Super-Structures on the Inactive X.

Authors:  Chen-Yu Wang; Teddy Jégu; Hsueh-Ping Chu; Hyun Jung Oh; Jeannie T Lee
Journal:  Cell       Date:  2018-06-07       Impact factor: 41.582

3.  SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.

Authors:  Natalie D Shaw; Harrison Brand; Zachary A Kupchinsky; Hemant Bengani; Lacey Plummer; Takako I Jones; Serkan Erdin; Kathleen A Williamson; Joe Rainger; Alexei Stortchevoi; Kaitlin Samocha; Benjamin B Currall; Donncha S Dunican; Ryan L Collins; Jason R Willer; Angela Lek; Monkol Lek; Malik Nassan; Shahrin Pereira; Tammy Kammin; Diane Lucente; Alexandra Silva; Catarina M Seabra; Colby Chiang; Yu An; Morad Ansari; Jacqueline K Rainger; Shelagh Joss; Jill Clayton Smith; Margaret F Lippincott; Sylvia S Singh; Nirav Patel; Jenny W Jing; Jennifer R Law; Nalton Ferraro; Alain Verloes; Anita Rauch; Katharina Steindl; Markus Zweier; Ianina Scheer; Daisuke Sato; Nobuhiko Okamoto; Christina Jacobsen; Jeanie Tryggestad; Steven Chernausek; Lisa A Schimmenti; Benjamin Brasseur; Claudia Cesaretti; Jose E García-Ortiz; Tatiana Pineda Buitrago; Orlando Perez Silva; Jodi D Hoffman; Wolfgang Mühlbauer; Klaus W Ruprecht; Bart L Loeys; Masato Shino; Angela M Kaindl; Chie-Hee Cho; Cynthia C Morton; Richard R Meehan; Veronica van Heyningen; Eric C Liao; Ravikumar Balasubramanian; Janet E Hall; Stephanie B Seminara; Daniel Macarthur; Steven A Moore; Koh-Ichiro Yoshiura; James F Gusella; Joseph A Marsh; John M Graham; Angela E Lin; Nicholas Katsanis; Peter L Jones; William F Crowley; Erica E Davis; David R FitzPatrick; Michael E Talkowski
Journal:  Nat Genet       Date:  2017-01-09       Impact factor: 38.330

4.  FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.

Authors:  Alexandra D Gurzau; Kelan Chen; Shifeng Xue; Weiwen Dai; Isabelle S Lucet; Thanh Thao Nguyen Ly; Bruno Reversade; Marnie E Blewitt; James M Murphy
Journal:  J Biol Chem       Date:  2018-05-10       Impact factor: 5.157

5.  Neuropathic MORC2 mutations perturb GHKL ATPase dimerization dynamics and epigenetic silencing by multiple structural mechanisms.

Authors:  Christopher H Douse; Stuart Bloor; Yangci Liu; Maria Shamin; Iva A Tchasovnikarova; Richard T Timms; Paul J Lehner; Yorgo Modis
Journal:  Nat Commun       Date:  2018-02-13       Impact factor: 14.919

6.  A ubiquitin-like domain is required for stabilizing the N-terminal ATPase module of human SMCHD1.

Authors:  Lars C Pedersen; Kaoru Inoue; Susan Kim; Lalith Perera; Natalie D Shaw
Journal:  Commun Biol       Date:  2019-07-10

7.  Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage.

Authors:  Yosuke Hiramuki; Stephen J Tapscott
Journal:  Skelet Muscle       Date:  2018-08-02       Impact factor: 4.912

8.  The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization.

Authors:  S Massah; J Jubene; F J S Lee; T V Beischlag; G G Prefontaine
Journal:  BMC Genet       Date:  2020-01-15       Impact factor: 2.797

Review 9.  Relating SMCHD1 structure to its function in epigenetic silencing.

Authors:  Alexandra D Gurzau; Marnie E Blewitt; Peter E Czabotar; James M Murphy; Richard W Birkinshaw
Journal:  Biochem Soc Trans       Date:  2020-08-28       Impact factor: 5.407

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.